5-MAPB: Difference between revisions

>Fick
m Amend to previous: forgot the second : at 2 effects
>JohntheCaptain
No edit summary
 
Line 23: Line 23:
{{effects/base
{{effects/base
|{{effects/physical|
|{{effects/physical|
*'''[[Effect::Stimulation]]''' -  In terms of its effects on the user's physical energy levels, 5-MAPB is commonly regarded as significantly less stimulating and energizing than [[MDMA]], while still retaining its core entactogenic effects. Unlike MDMA, which encourages activities such as running, climbing and dancing in a way that makes it a popular choice for musical events such as festivals and raves, the distinct style of stimulation which 5-MAPB presents can be described as mildly to moderately forced, trending more towards sedation and relaxation. This means that at higher doses, it becomes difficult or impossible to keep still as jaw clenching, involuntarily body shakes and vibrations become present, resulting in an extreme unsteadiness of the hands and a general lack of motor control, though to a far lesser degree than with MDMA.
*'''[[Effect::Stimulation]]''' -  In terms of its effects on the user's physical energy levels, 5-MAPB is commonly regarded as significantly less stimulating and energizing than MDMA, while still retaining its core entactogenic effects. Unlike MDMA, which encourages activities such as running, climbing and dancing in a way that makes it a popular choice for musical events such as festivals and raves, the distinct style of stimulation which 5-MAPB presents can be described as mildly to moderately forced, trending more towards sedation and relaxation. This means that at higher doses, it becomes difficult or impossible to keep still as jaw clenching, involuntarily body shakes and vibrations become present, resulting in an extreme unsteadiness of the hands and a general lack of motor control, though to a far lesser degree than with MDMA.
*'''[[Effect::Increased heart rate]]'''
*'''[[Effect::Dehydration]]'''
*'''[[Effect::Appetite suppression]]'''
*'''[[Effect::Appetite suppression]]'''
*'''[[Effect::Dehydration]]'''
*'''[[Effect::Increased heart rate]]'''
*'''[[Effect::Increased perspiration]]'''
*'''[[Effect::Muscle contractions]]'''
*'''[[Effect::Nausea]]'''  
*'''[[Effect::Nausea]]'''  
*'''[[Effect::Temporary erectile dysfunction]]'''
*'''[[Effect::Temporary erectile dysfunction]]'''
*'''[[Effect::Pupil dilation]]'''
*'''[[Effect::Increased perspiration]]'''
*'''[[Effect::Tactile enhancement]]''' - When compared to [[MDMA]], the tactile enhancement is present though a lot weaker.
*'''[[Effect::Nystagmus]]'''
*'''[[Effect::Teeth grinding]]'''
 
*'''[[Effect::Vibrating vision]]'''
}}
}}


{{effects/visual|
{{effects/visual|
*'''[[Effect::Acuity enhancement]]'''
*'''[[Effect::Acuity enhancement]]'''
*'''[[Effect::Colour enhancement]]'''
 
}}
}}


Line 45: Line 42:
The cognitive effects of 5-MAPB are mostly comparable to [[MDMA]], but missing the physical and mental stimulation that would be associated. Instead, it focuses mostly on serotonergic activity, leading to more pronounced feelings of empathy, euphoria and a general relaxed state of mind. At higher dosages, this becomes less apparent as physical and cognitive side effects appear which can result in states of confusion and restlessness perhaps more severe than with MDMA. It also shares many of its effects with [[5-APB]].
The cognitive effects of 5-MAPB are mostly comparable to [[MDMA]], but missing the physical and mental stimulation that would be associated. Instead, it focuses mostly on serotonergic activity, leading to more pronounced feelings of empathy, euphoria and a general relaxed state of mind. At higher dosages, this becomes less apparent as physical and cognitive side effects appear which can result in states of confusion and restlessness perhaps more severe than with MDMA. It also shares many of its effects with [[5-APB]].


*'''[[Effect::Empathy, love, and sociability enhancement]]'''
*'''[[Effect::Focus enhancement]]'''
*'''[[Effect::Thought acceleration]]'''
*'''[[Effect::Analysis enhancement]]'''
*'''[[Effect::Analysis enhancement]]'''
*'''[[Effect::Wakefulness]]'''
*'''[[Effect::Memory enhancement]]'''
*'''[[Effect::Motivation enhancement]]'''
*'''[[Effect::Cognitive euphoria|Euphoria]]'''
*'''[[Effect::Cognitive euphoria|Euphoria]]'''
*'''[[Effect::Compulsive redosing]]'''
*'''[[Effect::Compulsive redosing]]'''
*'''[[Effect::Empathy, love, and sociability enhancement]]'''
*'''[[Effect::Focus enhancement]]'''
*'''[[Effect::Increased music appreciation]]'''
*'''[[Effect::Increased music appreciation]]'''
*'''[[Effect::Memory enhancement]]'''
*'''[[Effect::Motivation enhancement]]'''
*'''[[Effect::Thought acceleration]]'''
*'''[[Effect::Wakefulness]]'''


}}
}}
Line 110: Line 107:
*'''Luxembourg:''' 5-MAPB is not cited in the list of prohibited substances<ref>Loi du 19 février 1973 concernant la vente de substances médicamenteuses et la lutte contre la toxicomanie. | <nowiki>http://legilux.public.lu/eli/etat/leg/loi/1973/02/19/n1/jo</nowiki></ref>. Therefore, it is still a legal substance.
*'''Luxembourg:''' 5-MAPB is not cited in the list of prohibited substances<ref>Loi du 19 février 1973 concernant la vente de substances médicamenteuses et la lutte contre la toxicomanie. | <nowiki>http://legilux.public.lu/eli/etat/leg/loi/1973/02/19/n1/jo</nowiki></ref>. Therefore, it is still a legal substance.
*'''Switzerland''': 5-MAPB is a controlled substance specifically named under Verzeichnis E.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref>
*'''Switzerland''': 5-MAPB is a controlled substance specifically named under Verzeichnis E.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref>
*'''United Kingdom''': 5-MAPB is a Class B drug.
*'''United Kingdom''': 5-MAPB is a Class B drug.<ref>UK Home Office (2014-03-05). "[https://www.legislation.gov.uk/ukdsi/2014/9780111110904 The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014]". UK Government. Retrieved 2014-03-11.</ref>
*'''United States''': 5-MAPB could be considered an analogue of [[MDA]] and therefore would be covered under the Federal Analogue Act if intended for human consumption.
*'''United States''': 5-MAPB could be considered an analogue of [[MDA]] and therefore would be covered under the Federal Analogue Act if intended for human consumption.


Retrieved from "http://psy.st/wiki/5-MAPB"